With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling ...

The DWP's PIP benefits are still available despite potential changes and could get you £812 a month if you have one of these ...

Xentria, a clinical-stage biopharmaceutical company advancing therapies for rare and serious diseases, today announced the successful completion of enrollment in the therapeutic dose-ranging phase of ...

In a new report out last week based in part on pollen scores, Tulsa ranked fourth among the most allergy-affected cities ...

A new medical review published in the Journal of Occupational Medicine and Toxicology has uncovered a troubling rise in ...

Tulisa sported a dramatic swipe of makeup in a stunning Instagram snap on Wednesday after performing at The Gaydio Awards in ...

Clinical-stage biotech company aTyr Pharma (ATYR) has seen a significant 24% increase in stock value over the past week, as the company posted ...

Q4 2024 Earnings Call Transcript March 13, 2025 aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. Operator: Good afternoon, ladies and gentlemen, and ...

Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...

Liz Kendall will set out how the government intends to reform the health benefits system on Tuesday afternoon, in a move ...

Rare diseases - a medical condition so obscure that even your doctor has to Google. Despite their name, these diseases ...